Full video transcriptClick to expand
Auto-generated transcript of @clay.cognitiv's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I love stimulants and so do most of you guys.
- 0:01As anybody with experience can tell you
- 0:03they're not exactly side effect free.
- 0:04One of the several things that I use
- 0:05to mitigate these side effects is pinilon.
- 0:07That means massively increased dopamine,
- 0:08increases oxidation and thus reactive oxygen species
- 0:10and thus oxidative stress.
- 0:11Increases in oxidative stress can ruin your sleep
- 0:13which causes even more oxidative stress.
- 0:15Increasing stress can ruin your mood,
- 0:16your mental clarity and your executive function in general.
- 0:18Pinilon reduces this oxidative stress.
- 0:20Plenty of other studies outlining the things
- 0:21that it may be doing positively
- 0:22but we don't actually have that much data yet
- 0:24and I don't really care.
- 0:25What I do care about is not suffering
- 0:26a lot of the side effects from stimulants
- 0:27and having better sleep, better mood,
- 0:29better regulation.
- 0:29Of course your mouth is made very,
- 0:30but this is one of my staples for stimulant use in general.
Semax and selank for ADHD: what the research actually supports
Quick answer
Pinealon is a synthetic tetrapeptide studied primarily in Russian gerontology research for neuroprotective and antioxidant effects in aging models. The creator's claim that it mitigates stimulant-induced oxidative stress is mechanistically plausible but entirely unsupported by human clinical trial data. No regulatory body has approved pinealon for any indication, and its safety and efficacy in stimulant-using populations has not been studied.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax and selank for ADHD: what the research actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Semax and selank for ADHD: what the research actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Semax and selank for ADHD: what the research actually supports" from Clay. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Pinealon is a synthetic tetrapeptide studied primarily in Russian gerontology research for neuroprotective and antioxidant effects in aging models.
The reason this review is not generic is the source wording and the canonical claim label "peptides more of an experience vid than a dive tbh i like it though y." In this clip, the useful excerpt is: "I love stimulants and so do most of you guys." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Pinealon is a synthetic tetrapeptide studied primarily in Russian gerontology research for neuroprotective and antioxidant effects in aging models.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Pinealon is a synthetic tetrapeptide studied primarily in Russian gerontology research for neuroprotective and antioxidant effects in aging models. The creator's claim that it mitigates stimulant-induced oxidative stress is mechanistically plausible but entirely unsupported by human clinical trial data. No regulatory body has approved pinealon for any indication, and its safety and efficacy in stimulant-using populations has not been studied.
- Pinealon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide with no FDA approval and no human clinical trials supporting its use in stimulant side effect management.
- The stimulant-to-dopamine-to-oxidative-stress pathway is real: Volz et al. (1990) documented ROS generation from dopamine turnover in amphetamine models, but the chain is not as linear as the creator presents.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Pinealon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide with no FDA approval and no human clinical trials supporting its use in stimulant side effect management.
- The stimulant-to-dopamine-to-oxidative-stress pathway is real: Volz et al. (1990) documented ROS generation from dopamine turnover in amphetamine models, but the chain is not as linear as the creator presents.
- Nearly all pinealon research originates from Khavinson's group at the Saint Petersburg Institute of Bioregulation, raising questions about independent replication and publication bias.
- NAC (N-acetylcysteine) has a substantially larger human evidence base for antioxidant intervention in stimulant-related contexts than pinealon does.
- Sleep disruption from stimulants primarily involves direct adrenergic overstimulation, not just oxidative stress, so framing pinealon as a sleep fix via antioxidant action is an oversimplification.
- The creator accurately disclosed that evidence is thin and framed the content as personal experience, which is a higher standard of honesty than many peptide videos on TikTok meet.
- Anyone using stimulants and managing side effects with unregulated research peptides should be doing so with clinical supervision, not based on social media experience reports.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @clay.cognitiv actually say?
The creator describes using pinealon, a synthetic peptide, to manage the side effects of stimulants. Their core argument is that stimulants cause dopamine surges that increase reactive oxygen species and oxidative stress, which then wreck sleep and cognitive performance. Pinealon, they claim, reduces that oxidative stress. They're upfront that the data is thin and frame the video as an experience report, not a science lecture. That honesty matters when evaluating this.
The creator says "we don't actually have that much data yet and I don't really care," which is either refreshingly candid or a red flag depending on your risk tolerance. They also end on a vague note about individual variation, which at least signals they aren't overpromising.
Does the science back this up?
The stimulant-to-oxidative-stress pathway the creator describes is real and reasonably well-supported. The pinealon-as-antioxidant claim is less settled, but not fabricated. Pinealon is a tripeptide (Ala-Glu-Asp-Gly) developed in Russia, primarily studied by Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation. Their 2005 work in Bulletin of Experimental Biology and Medicine showed antioxidant activity in brain tissue models. A 2012 paper by Khavinson et al. in Advances in Gerontology reported neuroprotective effects in older animal models under oxidative conditions.
The problem is almost all of this research comes from one research group, in Russian institutions, in animal or in vitro settings. There are no randomized controlled trials in humans. The sleep improvement claim the creator makes is plausible given pinealon's theoretical mechanism, but there is no direct clinical evidence for it in stimulant users specifically.
What did they get wrong (or right)?
They got the biochemistry directionally right. Amphetamine-class stimulants do increase dopamine turnover, and that does generate reactive oxygen species as a metabolic byproduct. Volz et al. (1990, Pharmacology Biochemistry and Behavior) documented this in rodent models. The downstream link to disrupted sleep via oxidative stress is also supported, though it is more complex than the creator implies. Sleep disruption from stimulants involves multiple pathways, not just oxidative stress.
What they got wrong, or at least oversimplified: "massively increased dopamine" does not directly equal "massively increased oxidative stress" in a simple linear chain. Dopamine metabolism via monoamine oxidase generates hydrogen peroxide, which is oxidative, but the magnitude depends on dose, individual enzyme activity, and other factors. The creator presents this as a clean causal chain when it is not.
Calling pinealon a "staple" with no mention of sourcing, purity standards, or the fact that it is not FDA-approved for any use is a gap worth naming.
What should you actually know?
Pinealon is a research peptide. It is not approved by the FDA, not tested in large human trials, and its safety profile in long-term use is not established. If you are considering it, that is the starting point, not a footnote.
The oxidative stress angle is genuinely interesting as a research direction. There are better-studied compounds with antioxidant properties, including NAC (N-acetylcysteine), which has actual human trial data in stimulant contexts. Mardikian et al. (2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry) studied NAC in stimulant-related contexts with more rigorous methodology than anything available for pinealon.
The creator's framing as a personal experience video is fair, but TikTok's algorithm does not label it that way to viewers. At 15,000 views, some percentage of those watchers will try to source and use this compound without context. The "YMMV" in the caption does not do the heavy lifting needed here.
- Pinealon is unregulated, not FDA-approved, and primarily studied in Russia in animal models.
- If you are using stimulants and experiencing side effects, that conversation belongs with a clinician, not a peptide stack.
- The antioxidant mechanism the creator describes is plausible but not proven in humans in this context.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Clay · TikTok creator
15.3K views on this video
More of an experience vid than a dive tbh. I like it though YMMV. #fypシ #adhd #cognition #nootropic
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about pinealon (ala-glu-asp-gly)?
Pinealon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide with no FDA approval and no human clinical trials supporting its use in stimulant side effect management.
What does the video say about the stimulant-to-dopamine-to-oxidative-stress pathway?
The stimulant-to-dopamine-to-oxidative-stress pathway is real: Volz et al. (1990) documented ROS generation from dopamine turnover in amphetamine models, but the chain is not as linear as the creator presents.
What does the video say about nearly all pinealon research?
Nearly all pinealon research originates from Khavinson's group at the Saint Petersburg Institute of Bioregulation, raising questions about independent replication and publication bias.
What does the video say about nac (n-acetylcysteine) has a substantially larger human evidence base for?
NAC (N-acetylcysteine) has a substantially larger human evidence base for antioxidant intervention in stimulant-related contexts than pinealon does.
What does the video say about sleep disruption from stimulants primarily involves direct adrenergic overstimulation, not?
Sleep disruption from stimulants primarily involves direct adrenergic overstimulation, not just oxidative stress, so framing pinealon as a sleep fix via antioxidant action is an oversimplification.
What does the video say about the creator accurately disclosed?
The creator accurately disclosed that evidence is thin and framed the content as personal experience, which is a higher standard of honesty than many peptide videos on TikTok meet.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Clay, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.